Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stem Cells | 4 | 2024 | 3513 | 1.200 |
Why?
|
| Immune Evasion | 3 | 2024 | 361 | 0.790 |
Why?
|
| Hair Follicle | 2 | 2018 | 206 | 0.670 |
Why?
|
| Bowman Capsule | 1 | 2018 | 1 | 0.650 |
Why?
|
| Immunologic Surveillance | 1 | 2018 | 90 | 0.590 |
Why?
|
| Flow Cytometry | 4 | 2022 | 5843 | 0.590 |
Why?
|
| Glomerulonephritis | 1 | 2018 | 360 | 0.540 |
Why?
|
| CD8-Positive T-Lymphocytes | 6 | 2024 | 4516 | 0.540 |
Why?
|
| Listeriosis | 1 | 2016 | 150 | 0.500 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2024 | 3012 | 0.460 |
Why?
|
| Listeria monocytogenes | 1 | 2016 | 252 | 0.460 |
Why?
|
| Podocytes | 1 | 2018 | 416 | 0.460 |
Why?
|
| Autoimmunity | 2 | 2024 | 1332 | 0.450 |
Why?
|
| Wound Healing | 1 | 2024 | 2750 | 0.430 |
Why?
|
| Neutrophils | 1 | 2024 | 3709 | 0.390 |
Why?
|
| Antigen Presentation | 6 | 2024 | 1239 | 0.380 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 535 | 0.370 |
Why?
|
| Intestines | 1 | 2020 | 1894 | 0.360 |
Why?
|
| MicroRNAs | 3 | 2016 | 3748 | 0.360 |
Why?
|
| Dendritic Cells | 3 | 2018 | 2713 | 0.340 |
Why?
|
| Lentivirus | 1 | 2012 | 495 | 0.340 |
Why?
|
| T-Lymphocytes | 3 | 2022 | 10018 | 0.330 |
Why?
|
| Toll-Like Receptors | 1 | 2012 | 586 | 0.320 |
Why?
|
| Skin | 2 | 2020 | 4389 | 0.300 |
Why?
|
| Liver | 5 | 2016 | 7382 | 0.290 |
Why?
|
| Mice, Transgenic | 7 | 2024 | 9513 | 0.280 |
Why?
|
| Prediabetic State | 1 | 2012 | 524 | 0.280 |
Why?
|
| Tumor Escape | 2 | 2020 | 364 | 0.270 |
Why?
|
| Islets of Langerhans | 1 | 2012 | 1321 | 0.270 |
Why?
|
| Kidney Failure, Chronic | 1 | 2018 | 2452 | 0.260 |
Why?
|
| Immunity, Innate | 3 | 2024 | 3025 | 0.260 |
Why?
|
| Hepatocytes | 1 | 2012 | 1209 | 0.250 |
Why?
|
| SOXF Transcription Factors | 1 | 2024 | 29 | 0.240 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 4297 | 0.220 |
Why?
|
| Up-Regulation | 1 | 2012 | 4118 | 0.220 |
Why?
|
| Mitochondria | 1 | 2016 | 3528 | 0.210 |
Why?
|
| Neovascularization, Pathologic | 1 | 2012 | 2620 | 0.200 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 3473 | 0.190 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 5685 | 0.190 |
Why?
|
| SOXC Transcription Factors | 1 | 2020 | 41 | 0.190 |
Why?
|
| Ketones | 1 | 2021 | 181 | 0.180 |
Why?
|
| Furans | 1 | 2021 | 192 | 0.180 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2021 | 198 | 0.180 |
Why?
|
| Autoantigens | 1 | 2024 | 870 | 0.170 |
Why?
|
| Mice | 14 | 2024 | 80251 | 0.170 |
Why?
|
| Receptors, Progesterone | 2 | 2021 | 1109 | 0.170 |
Why?
|
| Animals | 18 | 2024 | 166558 | 0.170 |
Why?
|
| Phagocytes | 1 | 2021 | 293 | 0.170 |
Why?
|
| Thymus Gland | 1 | 2024 | 1220 | 0.170 |
Why?
|
| Tumor Microenvironment | 4 | 2024 | 3695 | 0.150 |
Why?
|
| NF-kappa B | 2 | 2023 | 2464 | 0.150 |
Why?
|
| Neoplasms | 2 | 2023 | 21715 | 0.150 |
Why?
|
| Nuclear Transfer Techniques | 1 | 2017 | 61 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 8 | 2024 | 21600 | 0.140 |
Why?
|
| Receptors, Estrogen | 2 | 2021 | 2168 | 0.140 |
Why?
|
| Integrins | 1 | 2020 | 840 | 0.130 |
Why?
|
| Poly I-C | 1 | 2016 | 114 | 0.130 |
Why?
|
| Integrin alpha Chains | 1 | 2016 | 93 | 0.130 |
Why?
|
| Immunotherapy | 2 | 2022 | 4593 | 0.130 |
Why?
|
| Mice, Knockout | 6 | 2024 | 14253 | 0.130 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2020 | 2468 | 0.130 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2021 | 1338 | 0.120 |
Why?
|
| Breast Neoplasms | 4 | 2023 | 20763 | 0.120 |
Why?
|
| Cell Line, Tumor | 4 | 2023 | 16667 | 0.110 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2013 | 107 | 0.110 |
Why?
|
| Adenoma | 1 | 2024 | 2139 | 0.110 |
Why?
|
| Antigens | 1 | 2018 | 1439 | 0.110 |
Why?
|
| Muscles | 1 | 2018 | 1583 | 0.110 |
Why?
|
| Antigens, Neoplasm | 1 | 2020 | 1975 | 0.110 |
Why?
|
| Genomic Instability | 1 | 2017 | 687 | 0.110 |
Why?
|
| Melanoma, Experimental | 1 | 2016 | 560 | 0.110 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2016 | 492 | 0.100 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2013 | 178 | 0.100 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2013 | 232 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2023 | 2856 | 0.100 |
Why?
|
| Mucopolysaccharidosis III | 1 | 2011 | 10 | 0.100 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2013 | 772 | 0.100 |
Why?
|
| Nucleic Acids | 1 | 2013 | 177 | 0.090 |
Why?
|
| Hydrolases | 1 | 2011 | 139 | 0.090 |
Why?
|
| Receptor, erbB-2 | 1 | 2021 | 2467 | 0.090 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2012 | 302 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 1215 | 0.090 |
Why?
|
| Cell Proliferation | 2 | 2023 | 10311 | 0.090 |
Why?
|
| Immunoblotting | 1 | 2013 | 1653 | 0.090 |
Why?
|
| Gene Transfer Techniques | 2 | 2012 | 1202 | 0.090 |
Why?
|
| DNA Replication | 1 | 2017 | 1378 | 0.090 |
Why?
|
| Interferon-alpha | 1 | 2013 | 902 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2022 | 4057 | 0.080 |
Why?
|
| Point Mutation | 1 | 2014 | 1600 | 0.080 |
Why?
|
| Hyperplasia | 1 | 2012 | 1154 | 0.080 |
Why?
|
| Killer Cells, Natural | 1 | 2018 | 2170 | 0.080 |
Why?
|
| Insulin-Secreting Cells | 2 | 2012 | 893 | 0.080 |
Why?
|
| Influenza, Human | 1 | 2019 | 1503 | 0.080 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2012 | 578 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 2017 | 2898 | 0.080 |
Why?
|
| Protein Isoforms | 1 | 2012 | 1689 | 0.070 |
Why?
|
| Hepacivirus | 1 | 2014 | 1367 | 0.070 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2012 | 1094 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4586 | 0.070 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2016 | 2029 | 0.070 |
Why?
|
| Humans | 16 | 2024 | 746630 | 0.070 |
Why?
|
| Antigens, CD | 1 | 2016 | 3903 | 0.060 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 1060 | 0.060 |
Why?
|
| Fibrosis | 1 | 2012 | 2012 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3787 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2012 | 1905 | 0.060 |
Why?
|
| Inflammation | 1 | 2024 | 10633 | 0.060 |
Why?
|
| Hepatitis C | 1 | 2014 | 1591 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2011 | 1330 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2024 | 6748 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 11584 | 0.060 |
Why?
|
| Interferon-gamma | 2 | 2024 | 3143 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 9193 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 9107 | 0.060 |
Why?
|
| Signal Transduction | 3 | 2021 | 23154 | 0.060 |
Why?
|
| Endoderm | 1 | 2024 | 154 | 0.050 |
Why?
|
| Macrophages | 2 | 2021 | 5664 | 0.050 |
Why?
|
| Cytokines | 2 | 2021 | 7236 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 6517 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 2 | 2020 | 1958 | 0.050 |
Why?
|
| Disease Progression | 2 | 2024 | 13317 | 0.050 |
Why?
|
| Eosinophils | 1 | 2024 | 939 | 0.040 |
Why?
|
| Taxoids | 1 | 2022 | 663 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 11050 | 0.040 |
Why?
|
| Insulin Resistance | 1 | 2012 | 3842 | 0.040 |
Why?
|
| Langerhans Cells | 1 | 2018 | 172 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2023 | 1137 | 0.040 |
Why?
|
| Organoids | 1 | 2024 | 705 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2021 | 714 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2012 | 3333 | 0.040 |
Why?
|
| Mitochondrial Proteins | 1 | 2023 | 979 | 0.040 |
Why?
|
| Dermis | 1 | 2018 | 200 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2020 | 2013 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2024 | 9320 | 0.030 |
Why?
|
| Interphase | 1 | 2017 | 228 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2012 | 18905 | 0.030 |
Why?
|
| Genome, Human | 2 | 2021 | 4358 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2021 | 5166 | 0.030 |
Why?
|
| Influenza A virus | 1 | 2019 | 453 | 0.030 |
Why?
|
| Female | 8 | 2023 | 382450 | 0.030 |
Why?
|
| Chromosome Segregation | 1 | 2017 | 234 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2019 | 1341 | 0.030 |
Why?
|
| Ligands | 1 | 2022 | 3269 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2024 | 2216 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2017 | 442 | 0.030 |
Why?
|
| Estrogens | 1 | 2021 | 1523 | 0.030 |
Why?
|
| Protein Precursors | 1 | 2018 | 1125 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 722 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2020 | 1801 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2019 | 1550 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2024 | 5416 | 0.030 |
Why?
|
| Apoptosis | 2 | 2023 | 9447 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 1979 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 3529 | 0.030 |
Why?
|
| RNA | 1 | 2022 | 2696 | 0.030 |
Why?
|
| Chromatin | 1 | 2024 | 2896 | 0.030 |
Why?
|
| Mitosis | 1 | 2017 | 1191 | 0.020 |
Why?
|
| Gene Order | 1 | 2011 | 170 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2017 | 1658 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 4823 | 0.020 |
Why?
|
| BRCA1 Protein | 1 | 2017 | 1131 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 2011 | 551 | 0.020 |
Why?
|
| Male | 3 | 2020 | 351420 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 6102 | 0.020 |
Why?
|
| Cell Survival | 1 | 2019 | 5764 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2011 | 1376 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2011 | 895 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 11966 | 0.020 |
Why?
|
| Mutation | 2 | 2024 | 29627 | 0.020 |
Why?
|
| DNA Repair | 1 | 2017 | 2017 | 0.020 |
Why?
|
| Plasmids | 1 | 2012 | 2275 | 0.020 |
Why?
|
| HIV Infections | 1 | 2013 | 16936 | 0.020 |
Why?
|
| Survival Rate | 1 | 2021 | 12645 | 0.020 |
Why?
|
| DNA Damage | 1 | 2017 | 2391 | 0.020 |
Why?
|
| Virus Replication | 1 | 2014 | 2455 | 0.020 |
Why?
|
| Peptides | 1 | 2018 | 4321 | 0.020 |
Why?
|
| Dependovirus | 1 | 2011 | 701 | 0.020 |
Why?
|
| Lysosomes | 1 | 2011 | 901 | 0.020 |
Why?
|
| Genomics | 1 | 2021 | 5695 | 0.020 |
Why?
|
| Pancreatitis | 1 | 2012 | 1098 | 0.020 |
Why?
|
| Cell Division | 1 | 2012 | 4440 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 8356 | 0.020 |
Why?
|
| Cerebellum | 1 | 2011 | 1486 | 0.010 |
Why?
|
| Visual Cortex | 1 | 2011 | 1099 | 0.010 |
Why?
|
| Base Sequence | 1 | 2014 | 12456 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 7572 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2011 | 3347 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 17689 | 0.010 |
Why?
|
| Lung | 1 | 2019 | 9918 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2011 | 10138 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2011 | 4868 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2021 | 63732 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 17869 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 164383 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 214618 | 0.000 |
Why?
|
| Adult | 1 | 2021 | 215192 | 0.000 |
Why?
|
Concepts
(196)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(39)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_